Biography
Dylan Hans is an associate in Weil’s Private Equity practice and is based in New York. Dylan participates in the representation of private equity sponsors and their portfolio companies with respect to mergers, acquisitions, divestitures and other corporate transactions.
Dylan has been part of the teams advising:
- Altamont Capital Partners in its close of its first continuation fund extending its investment and partnership with Tacala
- Blackstone in its $300 million acquisition of a minority stake in Recurrent Ventures
- Centerbridge Partners, L.P. and its portfolio company KIK Consumer Products Inc. in its sale of its automotive chemicals manufacturing business to an affiliate of Recochem Inc.
- CPP Investments, together with Blackstone, in the acquisition of Advarra, Inc., in a deal that implies an Advarra enterprise value of $5 billion
- ICG Strategic Equity in its acquisition of an indirect interest in Datavant Group
- Linden Structured Capital Fund in its $50 million preferred equity investment in the parent company of Aspen Surgical Products Holding, Inc.
- TRP Capital Partners in its single asset investment in GenOx Transportation
- TruArc Partners (f/k/a Snow Phipps Group) in its sale of AMAROK, LLC (f/k/a Electric Guard Dog, LLC)
Prior to joining Weil, Dylan was an associate at another international law firm.
Dylan received his J.D., cum laude, from Brooklyn Law School, where he was a member of the Brooklyn Law Review, as well as a recipient of the I. Leo Glasser Scholarship and CALI Awards for Criminal Law and Sports Law. He received his B.A. from Johns Hopkins University.